Biotech · Private company
ML Bio Solutions, Inc.
Track this companyFree. Adds ML Bio Solutions, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials43 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- BBP-418 (ribitol)Phase 3 · Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I)ClinicalTrials.gov · fetched Nov 12, 2026
- BBP-418Phase 2 · LGMD2IClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9PHASE3 · ACTIVE_NOT_RECRUITING · started Jun 5, 2026ClinicalTrials.gov NCT07678775 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I)PHASE3 · ACTIVE_NOT_RECRUITING · started May 31, 2023ClinicalTrials.gov NCT05775848 · fetched Nov 12, 2026
- Study of BBP-418 in Patients With LGMD2IPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 18, 2021ClinicalTrials.gov NCT04800874 · fetched Nov 12, 2026
- Biomarker Development in LGMD2iCOMPLETED · started Dec 1, 2019ClinicalTrials.gov NCT04202627 · fetched Nov 12, 2026